Skip to Content


In the US, Revlimid (lenalidomide systemic) is a member of the following drug classes: miscellaneous antineoplastics, other immunosuppressants and is used to treat Anemia, Lymphoma, Mantle Cell Lymphoma, Multiple Myeloma and Myelodysplastic Diseases.

US matches:

UK matches:

Ingredient matches for Revlimid


Lenalidomide is reported as an ingredient of Revlimid in the following countries:

  • Australia
  • Austria
  • Belgium
  • Bosnia & Herzegowina
  • Canada
  • Chile
  • Croatia (Hrvatska)
  • Czech Republic
  • Denmark
  • Ecuador
  • Egypt
  • Finland
  • France
  • Germany
  • Greece
  • Hong Kong
  • Hungary
  • Iceland
  • Ireland
  • Israel
  • Italy
  • Japan
  • Latvia
  • Lithuania
  • Mexico
  • Netherlands
  • New Zealand
  • Norway
  • Poland
  • Portugal
  • Spain
  • Sweden
  • Switzerland
  • Turkey
  • United Kingdom
  • United States

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.